‘Please don’t’: Woman says she’s in hospital with congestive heart failure, but begs Panera not to discontinue charged lemonades
Recently, Panera insiders revealed that the chain would be discontinuing its “Charged Sips” line of drinks. This news comes on the heels of several controversies involving the product. Numerous internet users have criticized the drink for its high caffeine content, and there have been several…#panera #chargedsips #tiktok #emilygraham #dearpaneraiam #ist #giant #brutal #tiktoker #dailydot (Source: Reuters: Health)
Source: Reuters: Health - May 13, 2024 Category: Consumer Health News Source Type: news

Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
NSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and congestive heart failure when administered in high doses to patients with AS.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 10, 2024 Category: Cardiology Tags: Rheumatology Clinical Summary Source Type: news

AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the AB-1002 program. AB-1002 is an investigational one-time gene therapy that is administered to the heart with the intention of helping to promote the production of a constitutively active form of protein inhibitor 1 (I-1c) designed to block the action of protein phosphatase 1. (Source: World Pharma News)
Source: World Pharma News - April 25, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

An urgent call for studies that address the cardiovascular consequences of legalization of marijuana - Rezkalla SH, Kloner RA.
In about a decade, half of the United States has legalized marijuana for recreational use. The drug has been associated with acute myocardial infarction, acute stroke, congestive heart failure, and various cardiac arrythmias. Data have shown that legalizat... (Source: SafetyLit)
Source: SafetyLit - April 24, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Suffering Shouldn ’ t Be a Normal Part of Womanhood
One of the most important lessons medical schools teach is one my mom mastered as a teenager left to fill her own mother’s shoes: how to figure out who is really sick and needs immediate attention and who can wait (or what we in the medical field call “triage”). Nothing I learned in med school or since has contradicted what I learned at Bertha’s knee. At the time, the practice of medicine was rudimentary—and that’s putting it nicely. So, the diagnoses typically made at home were probably not that different from those of a bona fide doctor. The more serious common ailments were things ...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Dr. Sharon Malone Tags: Uncategorized health Source Type: news

First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002 (also known as NAN-101) for the treatment of congestive heart failure (CHF). (Source: World Pharma News)
Source: World Pharma News - February 15, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Bayer & #039;s AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced the initiation of GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002 (also known as NAN-101) for the treatment of congestive heart failure (CHF). (Source: World Pharma News)
Source: World Pharma News - January 12, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Mayo Clinic Minute: How innovation is transforming heart transplants
Mayo Clinic doctors are using innovation to improve the lives of people who suffer from congestive heart failure and other chronic heart conditions. The Organ Care System, also known as "heart in a box, ” is potentially helping to expand the donor pool, which is crucial, considering that more than 4,000 people in the U.S. are waiting for a new heart. That’s according to the organization Donate Life America. Dr. Lisa LeMond, a Mayo Clinic cardiologist,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 29, 2023 Category: Databases & Libraries Source Type: news

CV Disease, Drug Abuse Big Contributors to Mortality in AS CV Disease, Drug Abuse Big Contributors to Mortality in AS
Congestive heart failure and renal disease were the strongest contributing comorbidities to mortality in hospitalized patients with ankylosing spondylitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

McConnell ’ s Bid to Downplay Freezes Undermined by History of Politicians Lying About Their Health
After Senate Minority Leader Mitch McConnell froze during a press conference this month, the Kentucky Republican’s second such episode this summer, his office released a note from the Capitol physician intended to calm those worried about his ability to continue at his job. Dr. Brian Monahan told McConnell in the letter that there was “no evidence that you have a seizure disorder or that you experienced a stroke, TIA or movement disorder such as Parkinson’s disease.” Monahan suggested the episodes may be related to the Leader’s concussion in March or to dehydration.  [time-brightcove n...
Source: TIME: Health - September 11, 2023 Category: Consumer Health News Authors: Mini Racker Tags: Uncategorized Congress Source Type: news

Why So Many Black Women Die in Pregnancy
BIRMINGHAM — Angelica Lyons knew it was dangerous for Black women to give birth in America. As a public health instructor, she taught college students about racial health disparities, including the fact that Black women in the U.S. are nearly three times more likely to die during pregnancy or delivery than any other race. Her home state of Alabama has the third-highest maternal mortality rate in the nation. Then, in 2019, it nearly happened to her. What should have been a joyous first pregnancy quickly turned into a nightmare when she began to suffer debilitating stomach pain. [time-brightcove not-tgx=”trueR...
Source: TIME: Health - May 23, 2023 Category: Consumer Health News Authors: Kat Stafford / AP Tags: Uncategorized Public Health wire Source Type: news

Catheter Ablation Improved EF in Persistent AF Patients Catheter Ablation Improved EF in Persistent AF Patients
This study found that regardless of congestive heart failure status, atrial fibrillation recurrence after catheter ablation for persistent AF is similar.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 1, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

People with severe obesity and a genetic pathway variant have increased risk of hypertension, Mayo Clinic research finds
ROCHESTER, Minn. — Obesity and its associated cardiometabolic issues are a major health concern in the U.S. and internationally. According to a study published in 2017, 12% of the world's adult population was affected by obesity in 2016, double the percentage from 30 years earlier. With obesity comes an increasing risk of cardiovascular disease, including stroke, congestive heart failure and myocardial infarction. Fortunately, obesity is a multifactorial disease that results from an energy balance dysregulation… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 18, 2023 Category: Databases & Libraries Source Type: news

ERLEADA ® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.
HORSHAM, Pa., April 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA® (apalutamide) in the United States. The introduction of the 240mg tablet provides the first-and-only option for a once-daily, single-tablet Androgen Receptor Inhibitor (ARI) approved for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).With two strengths available, healthcare professionals will have the flexibility to...
Source: Johnson and Johnson - April 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

AHA News: Back From Deployment, Air Force Member Diagnosed With Congestive Heart Failure
THURSDAY, March 23, 2023 (American Heart Association News) -- As a logistics planner with the U.S. Air Force, Kassandra Benson deployed to Pakistan, where she worked long days and nights coordinating and troubleshooting special operations troops ' ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 23, 2023 Category: General Medicine Source Type: news